Chimigen Biomedical
PrivateLast Round
Pre Seed
Jul 22, 2025
Total Funding Raised
$37.65M
Company Overview
Chimigen Biomedical is a clinical-stage biotechnology company that develops innovative immunotherapies and therapeutic vaccines for cancer and viral infections using its proprietary SynNeogen® platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chimigen Biomedical Comparables
Compare Chimigen Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cansino Biologics Inc. | 69% | |
| Sinovac Biotech Ltd. | 67% | |
| Beijing Wantai Biological Pharmacy Enterprise | 66% | |
Chimigen Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 22, 2025 | ||||
| Angel | Nov 1, 2022 |
Chimigen Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | Pre Seed, Angel |
| CAS Star | Pre Seed |
| SDIC Venture Capital | Pre Seed |
| Puhua Capital | Angel |
Chimigen Biomedical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Chimigen Biomedical's valuation, stock price, and market status.